Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Neoplasms × Imlunestrant × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Breast 1

Conditions

Breast Neoplasms 8 Neoplasm Metastasis 1 Endometrial Neoplasms 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Paclitaxel 80 Carboplatin 65 pembrolizumab 62 Cisplatin 25 Bevacizumab 25 Letrozole 21 Surveys and Questionnaires 20 Radiotherapy 20 Doxorubicin 20 olaparib 17 Megestrol Acetate 17 lenvatinib 16 Taxes 16 Specimen Handling 16 dostarlimab 15 Magnetic Resonance Spectroscopy 15 Docetaxel 15 Nivolumab 14 Observation 13 Metformin 13 Blood Specimen Collection 12 durvalumab 11 Medroxyprogesterone Acetate 11 Fulvestrant 11 temsirolimus 10 Indocyanine Green 10 Brachytherapy 10 Biopsy 10 abemaciclib 9 Trastuzumab 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04188548 2025-06-04

EMBER

Eli Lilly and Company

Phase 1 Active not recruiting

BreastGynecologic

Breast Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡